Lockheed Martin (LMT)

LOCKHEED MARTIN brand logo sign at office building location
DCStockPhotography/Shutterstock

Aerospace and defense giant Lockheed Martin has struggled to maintain altitude this year, but contrarian income investors might want to take a closer look.

Lockheed’s stock has been all over the place, partially because of growth concerns. When your biggest client is the U.S. government, whose defense spending is only increasing in the single digits, getting Wall Street excited about your long-term prospects can be difficult.

But Lockheed’s financials and existing revenue stream are both strong. Moreover, its 3.3% dividend yield is one of the highest of any industrial stock on the S&P 500.

And when was the last time you heard of the U.S. cutting its arms budget?

Burry owned 30,000 Lockheed shares as of Sept. 30, worth an estimated $10.3 million.

An app called Acorns automatically rounds up purchases made on your credit or debit card to the nearest dollar and places the excess "change" into a smart investment portfolio. You get $10 immediately from your first investment.

Get $10

Now Inc. (DNOW)

Oil pumps. Oil industry equipment.
huyangshu/Shutterstock

An industrial small-cap alternative to Lockheed is an under-the-radar company called Now Inc.

Now is a global industrial supplies company that distributes, maintains and repairs oil drilling equipment, so it’s no surprise that Now has benefitted mightily from the ongoing rally in the energy market.

The company’s stock is up more than 70% over the past year.

Over the past three years, Now has generated average annual free cash flow production of roughly $208 million.

But Now should have some long-term appeal, too, as the company has plans to diversify into growing sectors like renewable energy and carbon capture.

Burry seems to be high on what Now is offering. He owned 150,000 shares in the company as of Q3 2021.

Scynexis (SCYX)

Medical Research Laboratory
Gorodenkoff/Shutterstock

Scynexis is a biotechnology company that specializes in developing treatments for difficult to treat fungal infections, including those that regularly threaten the lives of hospital patients.

Prescriptions of Scynexis products are increasing, and a growing number of insurers are covering the costs.

Clinical tests show the company’s next big offering, ibrexafungerp, to be effective in treating a wide range of potentially deadly infections.

It may sound niche, but Scynexis’s technology, financials and upward trajectory were enough to entice Burry into buying more than 174,000 shares.

Scynexis shares are up 18% over the past year.

It seems like a tricky time to get into real estate, and being a landlord isn't as passive as you think. Look at these low-stress options instead.

Read More

There’s more to invest in than stocks

Woman Visiting Art Gallery Lifestyle Concept
Rawpixel.com/Shutterstock

If Burry is correct, and the market is headed for a historic meltdown, you might want to diversify outside of stocks.

Putting your money into real physical assets, like gold or real estate, can help shield your portfolio from extreme market volatility.

But there’s another category of real asset a lot of investors don’t realize they have access to: contemporary art, which has outperformed the S&P 500 by a whopping 175% since 1995.

You don’t have to don a tux and outbid a roomful of millionaires to own a piece of rapidly appreciating modern art.

A popular new investment platform allows you to buy shares in masterpieces by Claude Monet, Andy Warhol and even Banksy.

They won’t wind up on your wall, but they’ll look pretty sweet in your portfolio.

Never overpay on Amazon again

Make sure to price-check online purchases with the help of Capital One Shopping. It’s totally free to use and takes less than a minute to set up.

Last year the service saved its customers over $160 million, and with just a few clicks you can start saving, too.

Download Capital One Shopping today and stop paying more than you have to for the exact same stuff.

About the Author

Clayton Jarvis

Clayton Jarvis

Reporter

Clayton Jarvis is a mortgage reporter at MoneyWise. Prior to joining the MoneyWise team, Clay wrote for and edited a variety of real estate publications, including Canadian Real Estate Wealth, Real Estate Professional, Mortgage Broker News, Canadian Mortgage Professional, and Mortgage Professional America.

Disclaimer

The content provided on MoneyWise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter.